{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:23:58Z","timestamp":1790299438182,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.molmed.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T15:16:12Z","timestamp":1107875772000},"page":"104-113","source":"Crossref","is-referenced-by-count":52,"title":["Modulation of angiogenesis with siRNA inhibitors for novel therapeutics"],"prefix":"10.1016","volume":"11","author":[{"given":"Patrick Y.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Y.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","article-title":"Clinical translation of angiogenesis inhibitors","volume":"2","author":"Kerbel","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc863","article-title":"Lymphangiogenesis and cancer metastasis","volume":"2","author":"Stacker","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrg908","article-title":"Gene silencing in mammals by small interfering RNAs","volume":"3","author":"McManus","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2005.01.005_bib5","first-page":"225","article-title":"siRNA-mediated antitumorigenesis for drug target validation and therapeutics","volume":"5","author":"Lu","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.molmed.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2003.10.153","article-title":"RNA interference for HIF-1\u03b1 inhibits its downstream signalling and affects cellular proliferation","volume":"312","author":"Hanze","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/0008-5472.CAN-03-3044","article-title":"Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1359-4117.2003.01092.x","article-title":"siRNA agents inhibit oncogene expression and attenuate human tumor cell growth","volume":"3","author":"Yin","year":"2003","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.molmed.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00337.2003","article-title":"Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein","volume":"286","author":"Cui","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molmed.2005.01.005_bib10","unstructured":"Xie, F.Y. et al. (2004) Delivering siRNA to animal disease models for validation of novel drug targets in vivo. PharmaGenomics July\/August, 28\u201331"},{"key":"10.1016\/j.molmed.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1158\/0008-5472.CAN-03-2682","article-title":"A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics","volume":"64","author":"Takei","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib12","first-page":"210","article-title":"Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model","volume":"9","author":"Reich","year":"2003","journal-title":"Mol. Vis."},{"key":"10.1016\/j.molmed.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor-pathway genes; therapeutic strategy for herpetic stromal keratitis","volume":"165","author":"Kim","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"22267","DOI":"10.1074\/jbc.M312729200","article-title":"The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration","volume":"279","author":"Holmqvist","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.RES.0000136522.58649.60","article-title":"QGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation","volume":"95","author":"Yamaoka-Tojo","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gnh140","article-title":"Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically-stablilized nanoparticle","volume":"32","author":"Schiffelers","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumor angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"36537","DOI":"10.1074\/jbc.M304300200","article-title":"Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells","volume":"278","author":"Sanceau","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2004.05.174","article-title":"Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration","volume":"320","author":"Sweeney","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.01.005_bib21","first-page":"3069","article-title":"Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"20461","DOI":"10.1074\/jbc.M400264200","article-title":"Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1074\/jbc.M307356200","article-title":"Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration","volume":"279","author":"Murai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"49358","DOI":"10.1074\/jbc.M308071200","article-title":"CD13\/APN transcription is induced by RAS\/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells","volume":"278","author":"Petrovic","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1128\/MCB.23.19.6725-6738.2003","article-title":"Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro","volume":"23","author":"Cao","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"46029","DOI":"10.1074\/jbc.M306393200","article-title":"PACSIN3 binds ADAM12\/meltrin \u03b1 and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor","volume":"278","author":"Mori","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000071864","article-title":"Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death","volume":"13","author":"Walsh","year":"2003","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.molmed.2005.01.005_bib28","first-page":"1229","article-title":"Smad2 mediates Erk1\/2 activation by TGF-\u03b21 in suspended, but not in adherent, gastric carcinoma cells","volume":"24","author":"Lee","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molmed.2005.01.005_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2004.03.018","article-title":"c-Src-dependent cross-talk between CEACAM6 and \u03b1v\u03b23 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components","volume":"317","author":"Duxbury","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.01.005_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1535-6108(03)00281-2","article-title":"Regulation of tumor angiogenesis by integrin-linked kinase (ILK)","volume":"5","author":"Tan","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2005.01.005_bib31","doi-asserted-by":"crossref","first-page":"51324","DOI":"10.1074\/jbc.M309122200","article-title":"PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival","volume":"278","author":"Fukuda","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib32","doi-asserted-by":"crossref","first-page":"39882","DOI":"10.1074\/jbc.M304685200","article-title":"The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged","volume":"278","author":"Ding","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib33","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.M311668200","article-title":"Engagement of \u03b1v\u03b23 integrin regulates proliferation and apoptosis of hepatic stellate cells","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib34","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/jcs.00823","article-title":"The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress","volume":"116","author":"Tsuruta","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2005.01.005_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1025819521707","article-title":"Use of RNA interference to inhibit integrin (\u03b16\u03b24)-mediated invasion and migration of breast carcinoma cells","volume":"20","author":"Lipscomb","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.molmed.2005.01.005_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-4827(02)00050-2","article-title":"Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells","volume":"285","author":"Nagy","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib37","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1074\/jbc.M311153200","article-title":"Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2\/neu gene expression","volume":"279","author":"Yang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib38","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1074\/jbc.M310357200","article-title":"RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells","volume":"279","author":"Zhang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib39","first-page":"4801","article-title":"Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ncb1026","article-title":"Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis","volume":"5","author":"Reginato","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2005.01.005_bib41","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/emboj\/cdg231","article-title":"TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells","volume":"22","author":"Gschwind","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2005.01.005_bib42","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/MCB.22.22.7758-7768.2002","article-title":"Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases","volume":"22","author":"Shu","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2005.01.005_bib43","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1038\/sj.onc.1207633","article-title":"Activation of diacylglycerol kinase \u03b1 is required for VEGF-induced angiogenic signaling in vitro","volume":"23","author":"Baldanzi","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2005.01.005_bib44","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood-2004-05-1760","article-title":"VEGF induces MCL-1 upregulation and protects multiple myeloma cells against apoptosis","volume":"104","author":"Le Gouill","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2005.01.005_bib45","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2003-07-2459","article-title":"Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis","volume":"103","author":"Spagnuolo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2005.01.005_bib46","doi-asserted-by":"crossref","first-page":"42409","DOI":"10.1074\/jbc.M308709200","article-title":"Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK\/ERK pathway","volume":"278","author":"Calipel","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2003.10.078","article-title":"Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling","volume":"126","author":"Thamilselvan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2005.01.005_bib48","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1038\/sj.onc.1207473","article-title":"ILKAP regulates ILK signaling and inhibits anchorage-independent growth","volume":"23","author":"Kumar","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2005.01.005_bib49","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/sj.emboj.7600095","article-title":"DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent manner","volume":"23","author":"Meng","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2005.01.005_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(03)00281-3","article-title":"Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells","volume":"541","author":"Tseng","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2005.01.005_bib51","doi-asserted-by":"crossref","first-page":"33759","DOI":"10.1074\/jbc.M402055200","article-title":"Involvement of 3-phosphoinositide-dependent protein kinases-1 in the MEK\/MAPK signal-transduction pathway","volume":"279","author":"Sato","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib52","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1074\/jbc.M311891200","article-title":"TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib53","doi-asserted-by":"crossref","unstructured":"Lu, P.Y. and Woodle, M. (2005) Delivering siRNA in vivo For functional genomics can novel therapeutics. In RNA Interference Technology, pp. 303\u2013317, Cambridge University Press","DOI":"10.1017\/CBO9780511546402.025"},{"key":"10.1016\/j.molmed.2005.01.005_bib54","first-page":"3919","article-title":"siRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth","volume":"63","author":"Filleur","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/rheumatology\/keh281","article-title":"VEGF gene polymorphisms and susceptibility to rheumatoid arthritis","volume":"43","author":"Han","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.molmed.2005.01.005_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00365510410003732","article-title":"Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis","volume":"64","author":"Gudbjornsson","year":"2004","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.molmed.2005.01.005_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00011-003-1230-4","article-title":"Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787\/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis","volume":"53","author":"Grosios","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib58","first-page":"36","article-title":"Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab","volume":"52","author":"Klimiuk","year":"2004","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.molmed.2005.01.005_bib59","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.20037","article-title":"Novel tumor necrosis factor \u03b1-regulated genes in rheumatoid arthritis","volume":"50","author":"Zhang","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2005.01.005_bib60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2003.10.141","article-title":"Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells","volume":"312","author":"Miyashita","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.01.005_bib61","doi-asserted-by":"crossref","first-page":"21924","DOI":"10.1074\/jbc.M401178200","article-title":"Cryopyrin-induced interleukin 1\u03b2 secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC","volume":"279","author":"Dowds","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.01.005_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:PHAM.0000012145.49054.6c","article-title":"Pharmaceutical prospects for RNA interference","volume":"21","author":"Schiffelers","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.molmed.2005.01.005_bib63","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2005.01.005_bib64","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"Sledz","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2005.01.005_bib65","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.172.11.6545","article-title":"Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3","volume":"172","author":"Kariko","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2005.01.005_bib66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/nbt1038","article-title":"Lack of interferon response in animals to naked siRNAs","volume":"22","author":"Heidel","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2005.01.005_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/1061186042000207039","article-title":"Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system","volume":"11","author":"Beale","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.molmed.2005.01.005_bib68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1440-1681.2003.03801.x","article-title":"RNA interference may be more potent than antisense RNA in human cancer cell lines","volume":"30","author":"Aoki","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.molmed.2005.01.005_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/135965350400900310","article-title":"Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus","volume":"9","author":"Zheng","year":"2004","journal-title":"Antivir. Ther."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T02:39:32Z","timestamp":1682995172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491405000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1471491405000237"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2005.01.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}